SCHEMBL25929422

SCHEMBL25929422

CCCC(=O)c1ccc(OCCN2CCC3(CC2)C(=O)Nc2ccc(Cl)cc23)cc1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
IP6K1 Q92551 6/20 0.49
HRH2 P25021 5/20 0.48
HRH1 P35367 5/20 0.48
ALDH1A1 P00352 4/20 0.47
MEN1 O00255 1/20 0.47
KMT2A Q03164 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
DRD3 P35462 2/20 0.46
IP6K3 Q96PC2 1/20 0.46
IP6K2 Q9UHH9 1/20 0.46
THRB P10828 4/20 0.46
THRA P10827 1/20 0.46
HTR2A P28223 2/20 0.46
LMNA P02545 2/20 0.46
CYP1A2 P05177 1/20 0.46
CHRM2 P08172 1/20 0.46
CHRM4 P08173 1/20 0.46
CHRM5 P08912 1/20 0.46
CYP2D6 P10635 1/20 0.46
CYP2C9 P11712 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25928642 0.88 IP6K1 (0.45) IP6K1HRH2HRH1DRD3IP6K3
SCHEMBL25316705 0.88 IP6K1 (0.61) IP6K1ALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL30507360 0.88 IP6K1 (0.61) IP6K1ALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL30507031 0.86 IP6K1 (0.63) IP6K1ALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL25316240 0.86 IP6K1 (0.63) IP6K1ALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL25317536 0.83 HTR1A (0.49) IP6K1ALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL25315904 0.83 HTR1A (0.46) IP6K1ALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL30507068 0.82 IP6K1 (0.54) IP6K1ALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL25315886 0.82 IP6K1 (0.54) IP6K1ALDH1A1MEN1KMT2AL3MBTL1
SCHEMBL30506835 0.81 HTR1A (0.44) IP6K1ALDH1A1MEN1KMT2AL3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023141432-A2 APOL1 INHIBITORS AND METHODS OF USE MAZE THERAPEUTICS, INC. (US) 2023-07-27 WO disclosed